Growing Price Tag Reported for Newer De Facto Stroke Lytic

(MedPage Today) -- NEW ORLEANS -- Tenecteplase in recent years outpaced alteplase as the stroke thrombolytic of choice at one large hospital system, despite shrinking cost savings, a researcher reported here.
In 2021, clinicians at Cardinal...